AstraZeneca Pays $102 Million For Sumitomo Shares Of Japan Unit
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca said it has paid $102 million for all the shares Sumitomo Chemical held in AstraZeneca K.K. of Japan, giving the UK-based company full control of its unit.